Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study
Walwaikar, P.P.; Kulkarni, S.S.; Bargaje, R.S.
Journal of the Indian Medical Association 103(10): 559-560
2005
ISSN/ISBN: 0019-5847 PMID: 16498771 Document Number: 585119
The ENGIP-I study was conducted to investigate the efficacy, and safety of itopride in patients of gastro-oesophageal reflux disease. There were significant reductions in heartburn frequency, heartburn severity, gastro-oesophageal regurgitation frequency at day 3 only. ENGIP-I study concluded that itopride was well tolerated by patients and appears to be the drug of choice in patients with gastro-oesophageal reflux disease.